Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Aptevo Therapeutics Inc (APVO)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Aptevo Therapeutics Inc 2401 4TH AVE. SUITE 1050 SEATTLE WA 98121 USA

www.aptevotherapeutics.com P: 206-838-0500 F: 206-838-0503

Description:

Aptevo Therapeutics Inc. is a biotechnology company which focused on developing oncology and hematology therapeutics. The company's platform consists of ADAPTIR(TM). Its product pipeline includes WinRho (R) SDF, HepaGam B (R), VARIZIG(R) and IXINITY (R) which are in pre-clinical stage. Aptevo Therapeutics Inc. is based in Seattle, Washington.

Key Statistics

Overview:

Market Capitalization, $K 85,331
Shares Outstanding, K 21,440
Annual Sales, $ 36,430 K
Annual Net Income, $ -112,420 K
Last Quarter Sales, $ 6,170 K
Last Quarter Net Income, $ 24,240 K
36-Month Beta 3.83
% of Insider Shareholders 15.60%
% of Institutional Shareholders 32.22%

Growth:

1-Year Total Return 128.42%
3-Year Total Return 0.00%
5-Year Total Return 0.00%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Next Earnings Date 11/13/17
Earnings Per Share ttm -0.86
EPS Growth vs. Prev Qtr 126.42%
EPS Growth vs. Prev Year 117.50%
Annual Dividend Rate, $ 0.00
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00

APVO Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward 9.72
Price/Earnings to Growth N/A
Return on Equity % -28.03
Return on Assets % -17.46
Net Margin % N/A
Debt/Equity 0.36
Price/Sales 2.34
Price/Cash Flow N/A
Price/Book 0.94
Book Value/Share 4.22
Interest Coverage 0.00
Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
New Chart Menu
Right-click anywhere on the chart to open the Interactive Chart menu.